कृपया अन्य खोज का प्रयास करें
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Beth C. Seidenberg | 66 | 2016 | Independent Director |
Scott W. Morrison | 65 | 2020 | Independent Director |
Patrick Gerald Enright | 62 | 2020 | Independent Director |
Marshall Fordyce | 48 | 2016 | Founder, President, CEO & Director |
Maha Katabi | 50 | 2020 | Independent Director |
Kimball Hall | 56 | 2021 | Independent Director |
Michael M. Morrissey | 62 | 2022 | Independent Chairman of the Board |
Andrew Cheng | 56 | 2017 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है